NICOTINE POLARILEX

NICOTINE POLARILEX was reported 15151 times

NICOTINE POLARILEX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 177 0.5842
1 RHESUS INCOMPATIBILITY 68 0.5620
2 PLETHYSMOGRAPHY 14 0.5385
3 TRUNCUS ARTERIOSUS PERSISTENT 74 0.3719
4 TOBACCO POISONING 30 0.2778
5 MYOCARDIAL STUNNING 24 0.1791
6 TOBACCO INTERACTION 16 0.1441
7 LUNG DIFFUSION DISORDER 18 0.1146
8 FEMALE GENITAL TRACT FISTULA 181 0.1059
9 TOBACCO ABUSE 50 0.0936
10 NICOTINE DEPENDENCE 719 0.0923
11 CARDIAC SEPTAL DEFECT 54 0.0751
12 TREMOR NEONATAL 32 0.0717
13 MULTIPLE DRUG OVERDOSE ACCIDENTAL 32 0.0700
14 RADICULOPATHY 180 0.0682
15 CONGENITAL CARDIOVASCULAR ANOMALY 57 0.0679
16 WEIGHT DECREASE NEONATAL 13 0.0670
17 NEUTROPENIA NEONATAL 15 0.0670
18 TOOTH EROSION 81 0.0661
19 PROCTITIS 183 0.0653
20 CHRONIC SINUSITIS 239 0.0636
21 POSTMORTEM BLOOD DRUG LEVEL INCREASED 19 0.0509
22 IDIOPATHIC INTERSTITIAL PNEUMONIA 18 0.0508
23 JAUNDICE NEONATAL 96 0.0507
24 CONGENITAL TRICUSPID VALVE INCOMPETENCE 10 0.0500
25 MACULAR DEGENERATION 563 0.0471
26 MEDIASTINAL MASS 18 0.0470
27 ADENOIDECTOMY 18 0.0464
28 NECROSIS ISCHAEMIC 20 0.0434
29 PULMONARY EOSINOPHILIA 19 0.0415
30 NEONATAL ASPIRATION 13 0.0396
31 BREECH PRESENTATION 49 0.0389
32 RESPIRATORY GAS EXCHANGE DISORDER 14 0.0377
33 SUBSTANCE DEPENDENCE 25 0.0371
34 SPUTUM PURULENT 24 0.0365
35 EXPOSURE DURING BREAST FEEDING 114 0.0344
36 LOSS OF PROPRIOCEPTION 11 0.0342
37 EXPOSURE VIA BREAST MILK 129 0.0324
38 FOETAL DISORDER 27 0.0323
39 BRONCHIAL WALL THICKENING 19 0.0264
40 HYPERBILIRUBINAEMIA NEONATAL 15 0.0258
41 DRUG WITHDRAWAL SYNDROME NEONATAL 381 0.0257
42 FOETAL DISTRESS SYNDROME 54 0.0254
43 GASTROSCHISIS 12 0.0252
44 DIAPHRAGMATIC DISORDER 19 0.0248
45 DRUG DETOXIFICATION 21 0.0235
46 LOW BIRTH WEIGHT BABY 175 0.0220
47 TOBACCO USER 32 0.0216
48 AGITATION NEONATAL 20 0.0209
49 PRODUCT ADHESION ISSUE 733 0.0205
50 SUBSTANCE ABUSE 165 0.0203
51 PNEUMONIA STREPTOCOCCAL 22 0.0201
52 SECONDARY IMMUNODEFICIENCY 24 0.0198
53 ALCOHOL ABUSE 51 0.0191
54 PULMONARY GRANULOMA 21 0.0184
55 VAGINAL DISCHARGE 182 0.0180
56 MICROCEPHALY 22 0.0171
57 CLEFT LIP 15 0.0171
58 UMBILICAL CORD AROUND NECK 10 0.0170
59 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 21 0.0167
60 MULTIPLE DRUG OVERDOSE 80 0.0161
61 ALCOHOL WITHDRAWAL SYNDROME 14 0.0161
62 PARAESTHESIA ORAL 229 0.0159
63 PREMATURE DELIVERY 252 0.0158
64 INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE 10 0.0156
65 VENTRICULAR SEPTAL DEFECT 89 0.0155
66 BORDERLINE PERSONALITY DISORDER 11 0.0155
67 PRESSURE OF SPEECH 10 0.0154
68 PLACENTA PRAEVIA 12 0.0153
69 HEART DISEASE CONGENITAL 54 0.0152
70 BRONCHIAL SECRETION RETENTION 19 0.0149
71 ORAL CANDIDIASIS 192 0.0146
72 FEEDING DISORDER NEONATAL 15 0.0143
73 CARDIAC DEATH 17 0.0141
74 ACCIDENTAL DEATH 26 0.0140
75 OPHTHALMOPLEGIA 22 0.0139
76 NEONATAL RESPIRATORY DISTRESS 13 0.0138
77 AXONAL NEUROPATHY 12 0.0137
78 APPLICATION SITE SCAR 17 0.0136
79 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 26 0.0132
80 COUNTERFEIT PRODUCT ADMINISTERED 17 0.0130
81 ANTISOCIAL BEHAVIOUR 13 0.0130
82 ALCOHOL INTERACTION 25 0.0129
83 BRONCHIAL HYPERREACTIVITY 15 0.0125
84 TREATMENT NONCOMPLIANCE 666 0.0122
85 JAW FRACTURE 26 0.0120
86 MYOCARDIAL FIBROSIS 10 0.0119
87 TONSILLECTOMY 19 0.0114
88 NEONATAL DISORDER 18 0.0114
89 NEUROPSYCHIATRIC SYMPTOMS 10 0.0111
90 MYCOBACTERIAL INFECTION 19 0.0110
91 PREMATURE BABY 324 0.0108
92 APPLICATION SITE DERMATITIS 10 0.0107
93 NON-ALCOHOLIC STEATOHEPATITIS 11 0.0106
94 PULPITIS DENTAL 10 0.0106
95 PLACENTAL DISORDER 10 0.0106
96 NASAL OEDEMA 19 0.0105
97 RESPIRATORY DISORDER NEONATAL 17 0.0105
98 PREMATURE SEPARATION OF PLACENTA 16 0.0104
99 CLEFT PALATE 20 0.0103
100 DENTAL CARIES 113 0.0102
101 SCHIZOAFFECTIVE DISORDER 18 0.0101
102 PRINZMETAL ANGINA 10 0.0101
103 DISINHIBITION 16 0.0099
104 CLEFT LIP AND PALATE 11 0.0098
105 OLIGOHYDRAMNIOS 32 0.0096
106 METHAEMOGLOBINAEMIA 22 0.0095
107 BONE DEMINERALISATION 10 0.0094
108 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 10 0.0094
109 RHONCHI 13 0.0094
110 FOETAL EXPOSURE DURING PREGNANCY 752 0.0092
111 ANTIPSYCHOTIC DRUG LEVEL INCREASED 26 0.0092
112 INTENTIONAL DRUG MISUSE 190 0.0091
113 GASTRIC DILATATION 15 0.0090
114 APPLICATION SITE URTICARIA 20 0.0089
115 BODY TEMPERATURE ABNORMAL 16 0.0087
116 APPLICATION SITE PRURITUS 196 0.0086
117 APPLICATION SITE WARMTH 11 0.0086
118 GESTATIONAL HYPERTENSION 11 0.0085
119 GAMBLING DISORDER 23 0.0085
120 EXPOSURE VIA FATHER 11 0.0084
121 SUBSTANCE USE 13 0.0083
122 APPLICATION SITE ERYTHEMA 218 0.0083
123 COMPULSIVE SHOPPING 17 0.0083
124 NEPHROGENIC ANAEMIA 38 0.0082
125 CLOSTRIDIUM TEST POSITIVE 18 0.0082
126 APPLICATION SITE RASH 112 0.0081
127 DRUG EFFECT INCREASED 25 0.0079
128 INCORRECT DRUG ADMINISTRATION DURATION 221 0.0079
129 BLOOD IMMUNOGLOBULIN E INCREASED 19 0.0078
130 MEAN CELL VOLUME DECREASED 12 0.0078
131 APPLICATION SITE VESICLES 50 0.0077
132 PRODUCT MONITORING ERROR 11 0.0076
133 GUN SHOT WOUND 14 0.0074
134 PROCEDURAL PAIN 203 0.0073
135 FREQUENT BOWEL MOVEMENTS 197 0.0073
136 ABNORMAL DREAMS 201 0.0073
137 DRUG SCREEN POSITIVE 57 0.0072
138 MEAN CELL HAEMOGLOBIN DECREASED 13 0.0071
139 ALCOHOL POISONING 19 0.0071
140 EMPHYSEMA 71 0.0070
141 REGURGITATION 24 0.0070
142 REBOUND ACID HYPERSECRETION 21 0.0069
143 PERIODONTITIS 15 0.0069
144 ABORTION INDUCED 65 0.0069
145 LEFT VENTRICULAR HYPERTROPHY 29 0.0068
146 CAESAREAN SECTION 78 0.0067
147 APPLICATION SITE BURN 33 0.0067
148 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 11 0.0066
149 LOBAR PNEUMONIA 12 0.0065
150 DRUG TOXICITY 88 0.0065
151 HYPERPARATHYROIDISM SECONDARY 16 0.0064
152 BRONCHIOLITIS 22 0.0062
153 PREMATURE LABOUR 35 0.0062
154 VITAMIN B12 DEFICIENCY 25 0.0062
155 MATERNAL DRUGS AFFECTING FOETUS 47 0.0061
156 OEDEMA MOUTH 20 0.0061
157 SMALL FOR DATES BABY 30 0.0060
158 DRUG ABUSER 37 0.0060
159 APPLICATION SITE SWELLING 30 0.0060
160 PRE-ECLAMPSIA 28 0.0059
161 RETROPERITONEAL HAEMATOMA 13 0.0059
162 HYPERTENSIVE HEART DISEASE 11 0.0059
163 DRUG USE DISORDER 49 0.0058
164 OBSTRUCTIVE AIRWAYS DISORDER 64 0.0057
165 BRONCHITIS CHRONIC 14 0.0057
166 COLITIS 215 0.0057
167 EUPHORIC MOOD 58 0.0057
168 PATENT DUCTUS ARTERIOSUS 22 0.0055
169 APPLICATION SITE IRRITATION 68 0.0055
170 AORTIC ARTERIOSCLEROSIS 14 0.0054
171 HOMICIDAL IDEATION 22 0.0054
172 ATELECTASIS 52 0.0054
173 NEONATAL RESPIRATORY DISTRESS SYNDROME 19 0.0054
174 UMBILICAL HERNIA 25 0.0053
175 RECTAL HAEMORRHAGE 229 0.0053
176 STENOSIS 10 0.0053
177 BILE DUCT OBSTRUCTION 10 0.0053
178 PRIAPISM 18 0.0052
179 ARTERIOSCLEROSIS CORONARY ARTERY 34 0.0051
180 MATERNAL EXPOSURE DURING PREGNANCY 454 0.0051
181 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 11 0.0050
182 GINGIVITIS 27 0.0050
183 APPLICATION SITE REACTION 35 0.0050
184 INTENTIONAL UNDERDOSE 36 0.0049
185 FUNCTIONAL GASTROINTESTINAL DISORDER 17 0.0049
186 FULL BLOOD COUNT ABNORMAL 52 0.0049
187 DRUG ABUSE 403 0.0048
188 TRANSFUSION 50 0.0048
189 VASODILATATION 12 0.0048
190 ECONOMIC PROBLEM 72 0.0047
191 MATERNAL EXPOSURE DURING BREAST FEEDING 19 0.0047
192 APPLICATION SITE DISCOLOURATION 19 0.0047
193 FOETAL GROWTH RESTRICTION 28 0.0046
194 COLITIS ULCERATIVE 204 0.0046
195 SNORING 17 0.0045
196 PRODUCT COMPLAINT 112 0.0044
197 ALCOHOL USE 16 0.0043
198 RED CELL DISTRIBUTION WIDTH INCREASED 18 0.0043
199 BIPOLAR DISORDER 47 0.0043
200 SELF-INJURIOUS IDEATION 18 0.0043
201 NIGHTMARE 146 0.0042
202 ALCOHOLISM 18 0.0042
203 APPLICATION SITE PAIN 92 0.0042
204 POTENTIATING DRUG INTERACTION 14 0.0042
205 SINUS TACHYCARDIA 59 0.0042
206 DRUG TOLERANCE 21 0.0041
207 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 293 0.0041
208 SUBSTANCE USE DISORDER 13 0.0041
209 NASAL POLYPS 20 0.0041
210 VENTRICULAR HYPOKINESIA 13 0.0040
211 POST-TRAUMATIC STRESS DISORDER 27 0.0040
212 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 210 0.0040
213 METABOLIC ENCEPHALOPATHY 12 0.0040
214 TOOTHACHE 72 0.0040
215 TOOTH FRACTURE 43 0.0039
216 OBSESSIVE-COMPULSIVE DISORDER 31 0.0039
217 LIP PAIN 11 0.0038
218 MUSCULOSKELETAL CHEST PAIN 59 0.0038
219 ANHEDONIA 100 0.0038
220 NON-CARDIAC CHEST PAIN 12 0.0038
221 INCORRECT PRODUCT ADMINISTRATION DURATION 82 0.0038
222 HAEMATOCHEZIA 207 0.0037
223 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 19 0.0037
224 MAJOR DEPRESSION 27 0.0037
225 SPUTUM DISCOLOURED 35 0.0037
226 ACCIDENTAL OVERDOSE 134 0.0037
227 END STAGE RENAL DISEASE 66 0.0036
228 ARTERIOSCLEROSIS 34 0.0036
229 RASH MORBILLIFORM 10 0.0036
230 TOXICITY TO VARIOUS AGENTS 605 0.0036
231 OVERDOSE 768 0.0036
232 PULMONARY CONGESTION 46 0.0035
233 MIOSIS 28 0.0035
234 EOSINOPHIL COUNT INCREASED 29 0.0035
235 LUNG CANCER METASTATIC 10 0.0035
236 PRODUCT ADMINISTRATION INTERRUPTED 27 0.0034
237 INFUSION RELATED REACTION 228 0.0034
238 PARTIAL SEIZURES 18 0.0034
239 LEFT VENTRICULAR DYSFUNCTION 23 0.0034
240 SCHIZOPHRENIA 41 0.0034
241 WRONG TECHNIQUE IN DRUG USAGE PROCESS 121 0.0033
242 BRAIN OEDEMA 42 0.0033
243 THROAT CANCER 14 0.0033
244 HALLUCINATION, AUDITORY 52 0.0033
245 MASTICATION DISORDER 10 0.0033
246 ISCHAEMIC CARDIOMYOPATHY 10 0.0033
247 TEARFULNESS 14 0.0033
248 DEPRESSION SUICIDAL 11 0.0032
249 SELF-MEDICATION 13 0.0032
250 TROPONIN INCREASED 24 0.0032
251 PULMONARY OEDEMA 141 0.0031
252 STILLBIRTH 15 0.0031
253 CARDIOPULMONARY FAILURE 12 0.0031
254 DERMATITIS CONTACT 35 0.0031
255 DYSPEPSIA 300 0.0030
256 MYOCLONUS 36 0.0030
257 GINGIVAL PAIN 24 0.0030
258 PEPTIC ULCER 10 0.0030
259 CARDIOMEGALY 37 0.0030
260 DRUG DEPENDENCE 478 0.0030
261 SPINAL OSTEOARTHRITIS 26 0.0030
262 PRODUCT QUALITY ISSUE 400 0.0029
263 AFFECTIVE DISORDER 23 0.0029
264 HICCUPS 24 0.0029
265 ENTEROCOCCAL INFECTION 14 0.0029
266 TACHYPHRENIA 10 0.0029
267 MULTIPLE INJURIES 18 0.0029
268 CHRONIC KIDNEY DISEASE 217 0.0029
269 NECROTISING FASCIITIS 10 0.0028
270 PRODUCT DOSE OMISSION 185 0.0028
271 EXPIRED DRUG ADMINISTERED 14 0.0028
272 PULMONARY MASS 42 0.0028
273 INGUINAL HERNIA 17 0.0028
274 UNRESPONSIVE TO STIMULI 72 0.0028
275 OROPHARYNGEAL DISCOMFORT 25 0.0028
276 MONOCYTE COUNT INCREASED 10 0.0028
277 DRUG DIVERSION 17 0.0027
278 RENAL TUBULAR NECROSIS 27 0.0027
279 WHEEZING 163 0.0027
280 WITHDRAWAL SYNDROME 115 0.0027
281 EXPOSURE DURING PREGNANCY 170 0.0027
282 FEELING JITTERY 52 0.0027
283 HYPOMANIA 10 0.0027
284 SEROTONIN SYNDROME 52 0.0027
285 MENTAL STATUS CHANGES 75 0.0027
286 SALIVARY HYPERSECRETION 27 0.0027
287 UNDERDOSE 194 0.0027
288 MYOCARDITIS 30 0.0026
289 ABSCESS LIMB 11 0.0026
290 LUNG NEOPLASM 11 0.0026
291 MITRAL VALVE INCOMPETENCE 29 0.0026
292 TOOTH ABSCESS 26 0.0026
293 GESTATIONAL DIABETES 12 0.0025
294 MALNUTRITION 28 0.0025
295 PANIC REACTION 18 0.0025
296 PERIPHERAL ISCHAEMIA 10 0.0024
297 LOSS OF LIBIDO 22 0.0024
298 IRON DEFICIENCY 11 0.0024
299 EXERCISE TOLERANCE DECREASED 14 0.0024
300 CONCOMITANT DISEASE AGGRAVATED 15 0.0024
301 HYPOXIA 85 0.0024
302 PRE-EXISTING CONDITION IMPROVED 15 0.0024
303 IRRITABILITY 144 0.0024
304 OSTEOPENIA 36 0.0024
305 DEAFNESS UNILATERAL 13 0.0024
306 PSYCHOMOTOR HYPERACTIVITY 39 0.0023
307 HYPERLIPIDAEMIA 28 0.0023
308 ANGER 79 0.0023
309 PARANOIA 40 0.0023
310 DRUG INTERACTION 365 0.0023
311 ISCHAEMIC STROKE 41 0.0023
312 DRUG LEVEL INCREASED 38 0.0023
313 ELECTROCARDIOGRAM ABNORMAL 18 0.0023
314 TRICUSPID VALVE INCOMPETENCE 18 0.0023
315 OLIGURIA 14 0.0023
316 THERMAL BURN 16 0.0023
317 SEDATION 59 0.0023
318 SOCIAL AVOIDANT BEHAVIOUR 13 0.0022
319 DRUG WITHDRAWAL SYNDROME 197 0.0022
320 RESTLESSNESS 82 0.0022
321 HEPARIN-INDUCED THROMBOCYTOPENIA 11 0.0022
322 TOOTH LOSS 46 0.0022
323 SHOCK HAEMORRHAGIC 18 0.0022
324 CARDIAC MURMUR 19 0.0022
325 HAEMOGLOBIN INCREASED 10 0.0022
326 DELIRIUM 76 0.0022
327 CORONARY ARTERY STENOSIS 11 0.0022
328 ORAL DISCOMFORT 30 0.0022
329 NEUTROPHIL COUNT INCREASED 22 0.0021
330 RESPIRATORY ARREST 59 0.0021
331 TENSION 13 0.0021
332 PANIC ATTACK 77 0.0021
333 EXPIRED PRODUCT ADMINISTERED 70 0.0021
334 PULSE ABSENT 10 0.0021
335 PSYCHOTIC DISORDER 62 0.0021
336 SUICIDAL IDEATION 191 0.0021
337 ACUTE RESPIRATORY FAILURE 40 0.0021
338 NYSTAGMUS 11 0.0021
339 OBESITY 33 0.0021
340 POISONING 26 0.0021
341 NERVE INJURY 23 0.0021
342 SLEEP APNOEA SYNDROME 39 0.0020
343 INCREASED APPETITE 39 0.0020
344 HEPATIC STEATOSIS 38 0.0020
345 ENERGY INCREASED 12 0.0020
346 INTENTIONAL PRODUCT MISUSE 176 0.0020
347 MOOD SWINGS 64 0.0020
348 DEPRESSED MOOD 106 0.0020
349 PLATELET COUNT INCREASED 26 0.0020
350 RESPIRATORY DISTRESS 55 0.0020
351 RESPIRATORY FAILURE 145 0.0020
352 NECROSIS 11 0.0020
353 DEPENDENCE 107 0.0019
354 ENDOCARDITIS 10 0.0019
355 COMPLETED SUICIDE 162 0.0019
356 CEREBRAL ISCHAEMIA 10 0.0019
357 PERIPHERAL VASCULAR DISORDER 10 0.0019
358 ATAXIA 23 0.0019
359 TACHYCARDIA 172 0.0019
360 PRODUCTIVE COUGH 92 0.0019
361 LOSS OF CONSCIOUSNESS 245 0.0019
362 TORSADE DE POINTES 15 0.0019
363 CONSTIPATION 416 0.0019
364 NERVOUSNESS 99 0.0019
365 VASCULITIS 22 0.0019
366 DROOLING 13 0.0019
367 ORAL PAIN 42 0.0019
368 TUBULOINTERSTITIAL NEPHRITIS 35 0.0019
369 ELECTROCARDIOGRAM QT PROLONGED 67 0.0019
370 DYSPNOEA EXERTIONAL 70 0.0019
371 AGITATION 136 0.0018
372 APATHY 27 0.0018
373 ANXIETY 526 0.0018
374 MYOCARDIAL ISCHAEMIA 21 0.0018
375 CYANOSIS 29 0.0018
376 PROTHROMBIN TIME PROLONGED 11 0.0018
377 REFUSAL OF TREATMENT BY PATIENT 12 0.0018
378 DYSARTHRIA 69 0.0018
379 GINGIVAL BLEEDING 25 0.0018
380 SOMNAMBULISM 12 0.0018
381 TYPE 1 DIABETES MELLITUS 11 0.0018
382 NEUTROPENIC SEPSIS 13 0.0018
383 PHARYNGEAL OEDEMA 28 0.0018
384 BRAIN INJURY 18 0.0018
385 SNEEZING 40 0.0018
386 ARTERIAL OCCLUSIVE DISEASE 14 0.0018
387 ANAL INCONTINENCE 16 0.0018
388 RENAL CYST 14 0.0018
389 MANIA 29 0.0018
390 DRUG ADMINISTRATION ERROR 54 0.0018
391 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 18 0.0018
392 BLOOD SODIUM DECREASED 33 0.0017
393 PALPITATIONS 205 0.0017
394 TOOTH INFECTION 23 0.0017
395 SENSORY LOSS 14 0.0017
396 ACUTE KIDNEY INJURY 265 0.0017
397 UPPER GASTROINTESTINAL HAEMORRHAGE 29 0.0017
398 HALLUCINATION 129 0.0017
399 FEELING OF BODY TEMPERATURE CHANGE 10 0.0017
400 HIATUS HERNIA 22 0.0017
401 CLOSTRIDIUM DIFFICILE COLITIS 18 0.0017
402 ABORTION SPONTANEOUS 68 0.0017
403 DIVERTICULUM 12 0.0017
404 RENAL INJURY 50 0.0017
405 SKIN PLAQUE 14 0.0017
406 COMA 79 0.0017
407 MENTAL DISORDER 72 0.0017
408 ERUCTATION 32 0.0017
409 RIB FRACTURE 34 0.0017
410 COLD SWEAT 29 0.0016
411 CONVULSION 94 0.0016
412 ASPIRATION 18 0.0016
413 PNEUMONIA ASPIRATION 41 0.0016
414 AGGRESSION 82 0.0016
415 ELECTROLYTE IMBALANCE 19 0.0016
416 VENTRICULAR TACHYCARDIA 27 0.0016
417 SKIN REACTION 23 0.0016
418 LOWER GASTROINTESTINAL HAEMORRHAGE 12 0.0016
419 INTERVERTEBRAL DISC DEGENERATION 15 0.0016
420 OXYGEN SATURATION DECREASED 91 0.0016
421 HYPERHIDROSIS 208 0.0016
422 LEUKOCYTOSIS 29 0.0016
423 INFUSION SITE SWELLING 10 0.0016
424 PAIN IN JAW 45 0.0016
425 SLEEP DISORDER 112 0.0016
426 ABNORMAL FAECES 13 0.0016
427 ABDOMINAL PAIN 368 0.0016
428 FORMICATION 11 0.0016
429 HEPATITIS C 19 0.0016
430 ANAEMIA 300 0.0016
431 ACUTE CORONARY SYNDROME 13 0.0016
432 DISSEMINATED INTRAVASCULAR COAGULATION 22 0.0016
433 ERYTHEMA 321 0.0016
434 LIVE BIRTH 13 0.0016
435 HYPERCHOLESTEROLAEMIA 15 0.0016
436 ATRIAL SEPTAL DEFECT 13 0.0016
437 RESPIRATORY DEPRESSION 19 0.0015
438 HYPERKALAEMIA 54 0.0015
439 VITAMIN D DEFICIENCY 15 0.0015
440 CORONARY ARTERY OCCLUSION 21 0.0015
441 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 310 0.0015
442 BLOOD CREATINE PHOSPHOKINASE INCREASED 44 0.0015
443 RASH MACULO-PAPULAR 34 0.0015
444 INCONTINENCE 16 0.0015
445 BLOOD ALBUMIN DECREASED 12 0.0015
446 PERSONALITY CHANGE 14 0.0015
447 MUSCLE STRAIN 13 0.0015
448 CARDIAC ARREST 124 0.0015
449 DEPRESSION 341 0.0015
450 PRESCRIBED OVERDOSE 29 0.0015
451 RENAL FAILURE 199 0.0015
452 HYPOKALAEMIA 69 0.0015
453 ACUTE MYOCARDIAL INFARCTION 44 0.0015
454 CARDIOMYOPATHY 22 0.0015
455 MENTAL IMPAIRMENT 36 0.0015
456 INTENTIONAL OVERDOSE 95 0.0015
457 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 27 0.0015
458 DECUBITUS ULCER 12 0.0015
459 BLOOD TRIGLYCERIDES INCREASED 26 0.0015
460 LYMPHOCYTE COUNT DECREASED 26 0.0015
461 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 10 0.0015
462 DRUG EXPOSURE DURING PREGNANCY 50 0.0015
463 ENCEPHALOPATHY 36 0.0015
464 ANGINA PECTORIS 42 0.0015
465 MATERNAL EXPOSURE BEFORE PREGNANCY 10 0.0015
466 CELLULITIS 73 0.0014
467 SEPTIC SHOCK 63 0.0014
468 PRODUCT USE ISSUE 272 0.0014
469 DEPRESSED LEVEL OF CONSCIOUSNESS 57 0.0014
470 POOR QUALITY SLEEP 31 0.0014
471 INJURY 101 0.0014
472 OSTEOPOROSIS 59 0.0014
473 PRURITUS GENERALISED 31 0.0014
474 BACTERAEMIA 17 0.0014
475 CHEST PAIN 265 0.0014
476 HALLUCINATION, VISUAL 30 0.0014
477 PAPULE 10 0.0014
478 HEART RATE IRREGULAR 32 0.0014
479 EJECTION FRACTION DECREASED 22 0.0014
480 FEAR 38 0.0014
481 PRODUCT PREPARATION ERROR 29 0.0014
482 CARDIO-RESPIRATORY ARREST 59 0.0014
483 UROSEPSIS 13 0.0014
484 PRODUCT AVAILABILITY ISSUE 32 0.0014
485 DRY MOUTH 114 0.0014
486 INSOMNIA 374 0.0014
487 HYPERGLYCAEMIA 51 0.0014
488 TREMOR 231 0.0014
489 DRUG DOSE OMISSION 230 0.0014
490 BLOOD MAGNESIUM DECREASED 12 0.0014
491 OROPHARYNGEAL PAIN 128 0.0014
492 SMALL INTESTINAL OBSTRUCTION 17 0.0014
493 ORTHOSTATIC HYPOTENSION 24 0.0014
494 HEART RATE INCREASED 136 0.0014
495 GASTROOESOPHAGEAL REFLUX DISEASE 110 0.0014
496 ORAL DISORDER 10 0.0014
497 MOUTH HAEMORRHAGE 10 0.0014
498 FACE OEDEMA 23 0.0014
499 HAEMOPTYSIS 38 0.0014
500 HAEMATOCRIT DECREASED 27 0.0014
501 CONFUSIONAL STATE 220 0.0014
502 PALLOR 37 0.0014
503 NEUROLEPTIC MALIGNANT SYNDROME 16 0.0013
504 PREGNANCY 27 0.0013
505 ASPHYXIA 11 0.0013
506 HYPERAESTHESIA 11 0.0013
507 MALAISE 587 0.0013
508 MUSCLE RIGIDITY 16 0.0013
509 DISORIENTATION 53 0.0013
510 INTENTIONAL SELF-INJURY 27 0.0013
511 SINUS CONGESTION 18 0.0013
512 ABDOMINAL DISTENSION 139 0.0013
513 SPINAL COMPRESSION FRACTURE 11 0.0013
514 EMOTIONAL DISORDER 41 0.0013
515 MYDRIASIS 17 0.0013
516 BODY TEMPERATURE DECREASED 13 0.0013
517 DISTURBANCE IN ATTENTION 71 0.0013
518 SCAB 15 0.0013
519 WEIGHT DECREASED 367 0.0013
520 NAUSEA 1031 0.0013
521 HYPOTONIA 13 0.0013
522 GRAND MAL CONVULSION 12 0.0013
523 DECREASED ACTIVITY 14 0.0013
524 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 22 0.0013
525 CRYING 47 0.0013
526 THINKING ABNORMAL 24 0.0013
527 ABNORMAL BEHAVIOUR 51 0.0013
528 SCAR 22 0.0013
529 HYPOTHERMIA 13 0.0013
530 MUSCULOSKELETAL DISCOMFORT 22 0.0013
531 ASTHMA 144 0.0013
532 PHOTOSENSITIVITY REACTION 21 0.0013
533 EATING DISORDER 27 0.0013
534 SPINAL DISORDER 12 0.0013
535 FEBRILE NEUTROPENIA 84 0.0013
536 POISONING DELIBERATE 12 0.0013
537 C-REACTIVE PROTEIN INCREASED 46 0.0013
538 PNEUMOTHORAX 20 0.0013
539 CORONARY ARTERY DISEASE 38 0.0013
540 CARDIOGENIC SHOCK 18 0.0013
541 VENTRICULAR EXTRASYSTOLES 13 0.0013
542 AKATHISIA 17 0.0012
543 LUNG INFILTRATION 11 0.0012
544 BRONCHITIS 92 0.0012
545 RESPIRATORY RATE INCREASED 11 0.0012
546 NOCTURIA 15 0.0012
547 CIRCULATORY COLLAPSE 21 0.0012
548 RENAL FAILURE ACUTE 52 0.0012
549 POLYURIA 10 0.0012
550 CARDIOVASCULAR DISORDER 31 0.0012
551 HYPERSOMNIA 35 0.0012
552 DEVELOPMENTAL DELAY 11 0.0012
553 HYPOTENSION 244 0.0012
554 OSTEOMYELITIS 22 0.0012
555 TOOTH DISORDER 27 0.0012
556 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
557 FOOT FRACTURE 23 0.0012
558 ANAPHYLACTIC REACTION 67 0.0012
559 SKIN LESION 33 0.0012
560 PANCREATITIS ACUTE 27 0.0012
561 PLEURAL EFFUSION 73 0.0012
562 LETHARGY 69 0.0012
563 BRAIN NEOPLASM 11 0.0012
564 ROAD TRAFFIC ACCIDENT 50 0.0012
565 FIBROMYALGIA 29 0.0012
566 QUALITY OF LIFE DECREASED 16 0.0012
567 TOXIC SKIN ERUPTION 12 0.0012
568 INTERVERTEBRAL DISC PROTRUSION 26 0.0012
569 METABOLIC ACIDOSIS 38 0.0012
570 SUICIDE ATTEMPT 72 0.0012
571 BLOOD COUNT ABNORMAL 18 0.0012
572 PYREXIA 410 0.0012
573 HAEMATEMESIS 30 0.0012
574 MUSCLE TWITCHING 27 0.0012
575 HEAD INJURY 37 0.0012
576 GASTROENTERITIS 17 0.0012
577 ATRIOVENTRICULAR BLOCK 9 0.0012
578 ANURIA 10 0.0012
579 HYPERBILIRUBINAEMIA 12 0.0012
580 DRUG INEFFECTIVE 1524 0.0012
581 DIABETES MELLITUS 88 0.0012
582 TENDERNESS 12 0.0012
583 NECK PAIN 64 0.0011
584 IMPAIRED DRIVING ABILITY 13 0.0011
585 CARPAL TUNNEL SYNDROME 16 0.0011
586 GASTRITIS 30 0.0011
587 EMOTIONAL DISTRESS 138 0.0011
588 SYNCOPE 114 0.0011
589 SCRATCH 12 0.0011
590 HEADACHE 713 0.0011
591 BLOOD CHOLESTEROL INCREASED 53 0.0011
592 RESPIRATORY DISORDER 34 0.0011
593 HYPONATRAEMIA 64 0.0011
594 FEELING ABNORMAL 271 0.0011
595 BONE LOSS 17 0.0011
596 BLOOD PRESSURE SYSTOLIC INCREASED 22 0.0011
597 RETCHING 24 0.0011
598 BLISTER 63 0.0011
599 SWOLLEN TONGUE 35 0.0011
600 HEPATOMEGALY 11 0.0011
601 BLOOD CREATININE INCREASED 73 0.0011
602 NEUTROPENIA 152 0.0011
603 PULMONARY EMBOLISM 106 0.0011
604 DIZZINESS 556 0.0011
605 BLOOD PRESSURE DECREASED 74 0.0011
606 MUSCLE TIGHTNESS 18 0.0011
607 BLOOD POTASSIUM INCREASED 18 0.0011
608 INTENTIONAL PRODUCT USE ISSUE 97 0.0011
609 SPEECH DISORDER 58 0.0011
610 FAECES DISCOLOURED 24 0.0011
611 DYSPNOEA 626 0.0011
612 MUSCLE ATROPHY 14 0.0011
613 CHEST DISCOMFORT 113 0.0011
614 TACHYPNOEA 15 0.0011
615 RESTLESS LEGS SYNDROME 20 0.0011
616 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 78 0.0011
617 SHOCK 25 0.0011
618 BONE DENSITY DECREASED 34 0.0011
619 RASH GENERALISED 28 0.0011
620 COAGULOPATHY 18 0.0011
621 MASS 15 0.0011
622 INITIAL INSOMNIA 11 0.0011
623 BURSITIS 13 0.0011
624 TEMPERATURE INTOLERANCE 11 0.0011
625 SOMNOLENCE 214 0.0011
626 STATUS EPILEPTICUS 12 0.0011
627 PARAESTHESIA 167 0.0011
628 PULMONARY HYPERTENSION 22 0.0011
629 PRODUCT PACKAGING ISSUE 10 0.0011
630 GENERALISED OEDEMA 13 0.0010
631 SUBDURAL HAEMATOMA 15 0.0010
632 CYTOKINE RELEASE SYNDROME 21 0.0010
633 IMPAIRED QUALITY OF LIFE 15 0.0010
634 PRODUCT PHYSICAL ISSUE 21 0.0010
635 AFFECT LABILITY 10 0.0010
636 HYPERTENSION 220 0.0010
637 SINUS BRADYCARDIA 10 0.0010
638 ANKLE FRACTURE 16 0.0010
639 HYPOKINESIA 15 0.0010
640 DIZZINESS POSTURAL 10 0.0010
641 BLOOD POTASSIUM DECREASED 31 0.0010
642 BODY TEMPERATURE INCREASED 21 0.0010
643 PNEUMONITIS 28 0.0010
644 GLOSSODYNIA 23 0.0010
645 EOSINOPHILIA 18 0.0010
646 THROMBOTIC MICROANGIOPATHY 10 0.0010
647 HAEMORRHOIDS 20 0.0010
648 CHOKING 20 0.0010
649 ACUTE HEPATIC FAILURE 14 0.0010
650 HYPERSENSITIVITY 190 0.0010
651 HEPATIC CYTOLYSIS 13 0.0010
652 MIDDLE INSOMNIA 19 0.0010
653 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 183 0.0010
654 ROTATOR CUFF SYNDROME 13 0.0010
655 MYOCARDIAL INFARCTION 176 0.0010
656 SKIN ULCER 26 0.0010
657 ULCER 16 0.0010
658 BLOOD PRESSURE INCREASED 153 0.0010
659 EYE SWELLING 37 0.0010
660 HYPOGLYCAEMIA 48 0.0010
661 SEASONAL ALLERGY 14 0.0010
662 ADRENAL INSUFFICIENCY 12 0.0010
663 PRESYNCOPE 24 0.0010
664 DRUG LEVEL DECREASED 10 0.0010
665 INTESTINAL OBSTRUCTION 37 0.0010
666 GASTROINTESTINAL HAEMORRHAGE 82 0.0010
667 SEIZURE 112 0.0010
668 PHARYNGITIS 12 0.0010
669 GENERALISED TONIC-CLONIC SEIZURE 16 0.0010
670 DELUSION 15 0.0010
671 BRADYCARDIA 51 0.0010
672 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
673 THERAPEUTIC RESPONSE UNEXPECTED 43 0.0010
674 PAIN 587 0.0010
675 UPPER LIMB FRACTURE 19 0.0010
676 PERICARDIAL EFFUSION 22 0.0010
677 TYPE 2 DIABETES MELLITUS 32 0.0009
678 SEPSIS 106 0.0009
679 EPILEPSY 29 0.0009
680 INTERNATIONAL NORMALISED RATIO INCREASED 27 0.0009
681 HEMIPARESIS 16 0.0009
682 RENAL PAIN 10 0.0009
683 VOMITING 442 0.0009
684 HYPOTHYROIDISM 30 0.0009
685 WHITE BLOOD CELL COUNT INCREASED 36 0.0009
686 IMPAIRED WORK ABILITY 20 0.0009
687 RHABDOMYOLYSIS 39 0.0009
688 ANOREXIA 12 0.0009
689 DYSTONIA 18 0.0009
690 CONTRAINDICATED PRODUCT ADMINISTERED 28 0.0009
691 FLATULENCE 52 0.0009
692 HEPATOCELLULAR INJURY 13 0.0009
693 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 44 0.0009
694 BRONCHOSPASM 13 0.0009
695 SWELLING FACE 59 0.0009
696 NASAL CONGESTION 53 0.0009
697 MIGRAINE 86 0.0009
698 MEDICATION ERROR 50 0.0009
699 TRANSAMINASES INCREASED 20 0.0009
700 FEELING COLD 25 0.0009
701 LUNG DISORDER 44 0.0009
702 SKIN IRRITATION 41 0.0009
703 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 23 0.0009
704 PNEUMONIA 289 0.0009
705 DEEP VEIN THROMBOSIS 58 0.0009
706 SKIN DISCOLOURATION 41 0.0009
707 TRANSIENT ISCHAEMIC ATTACK 30 0.0009
708 PRODUCT TASTE ABNORMAL 12 0.0009
709 CHOLESTASIS 17 0.0009
710 ILEUS 11 0.0009
711 CHOLELITHIASIS 29 0.0009
712 HEART RATE DECREASED 31 0.0009
713 URINARY INCONTINENCE 26 0.0009
714 LUNG NEOPLASM MALIGNANT 36 0.0009
715 NEOPLASM 10 0.0009
716 URINARY RETENTION 29 0.0009
717 GASTRIC HAEMORRHAGE 10 0.0009
718 WEIGHT INCREASED 194 0.0009
719 AMNESIA 56 0.0009
720 COUGH 241 0.0009
721 WOUND 24 0.0009
722 ERECTILE DYSFUNCTION 22 0.0009
723 DIABETES MELLITUS INADEQUATE CONTROL 15 0.0008
724 DEHYDRATION 113 0.0008
725 OEDEMA PERIPHERAL 103 0.0008
726 MUCOSAL INFLAMMATION 22 0.0008
727 LOWER LIMB FRACTURE 16 0.0008
728 RASH PRURITIC 45 0.0008
729 INCORRECT DOSE ADMINISTERED 188 0.0008
730 HYPOAESTHESIA 123 0.0008
731 CEREBRAL INFARCTION 20 0.0008
732 RESPIRATORY TRACT CONGESTION 13 0.0008
733 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 14 0.0008
734 DYSURIA 30 0.0008
735 LIVER INJURY 20 0.0008
736 BLOOD BILIRUBIN INCREASED 22 0.0008
737 ANGIOEDEMA 36 0.0008
738 BURNING SENSATION 57 0.0008
739 HYPERCALCAEMIA 10 0.0008
740 DISABILITY 16 0.0008
741 DIPLOPIA 21 0.0008
742 SINUS DISORDER 16 0.0008
743 DYSGEUSIA 60 0.0008
744 AGRANULOCYTOSIS 15 0.0008
745 RASH MACULAR 28 0.0008
746 DECREASED APPETITE 186 0.0008
747 LEUKOPENIA 40 0.0008
748 HYPOAESTHESIA ORAL 12 0.0008
749 MULTIPLE FRACTURES 13 0.0008
750 SWELLING 74 0.0008
751 HYPOMAGNESAEMIA 11 0.0008
752 GASTRIC ULCER 15 0.0008
753 THROMBOCYTOPENIA 88 0.0008
754 FEELING HOT 48 0.0008
755 CEREBRAL HAEMORRHAGE 28 0.0008
756 DRUG PRESCRIBING ERROR 15 0.0008
757 ASTHENIA 293 0.0008
758 BACK PAIN 181 0.0008
759 BLOOD UREA INCREASED 13 0.0008
760 INFUSION SITE PAIN 10 0.0008
761 HOSPITALISATION 119 0.0008
762 LACTIC ACIDOSIS 25 0.0008
763 PHARMACEUTICAL PRODUCT COMPLAINT 20 0.0008
764 LOWER RESPIRATORY TRACT INFECTION 35 0.0008
765 THERAPY PARTIAL RESPONDER 12 0.0008
766 BLOOD ALKALINE PHOSPHATASE INCREASED 19 0.0008
767 DERMATITIS 16 0.0008
768 BALANCE DISORDER 66 0.0008
769 AGEUSIA 19 0.0008
770 CEREBROVASCULAR ACCIDENT 129 0.0008
771 STAPHYLOCOCCAL INFECTION 25 0.0008
772 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
773 LIVER FUNCTION TEST ABNORMAL 22 0.0008
774 OSTEOARTHRITIS 32 0.0008
775 FALL 250 0.0008
776 DIABETIC KETOACIDOSIS 18 0.0007
777 HIP FRACTURE 24 0.0007
778 HAEMOGLOBIN DECREASED 76 0.0007
779 DYSKINESIA 30 0.0007
780 BONE MARROW FAILURE 15 0.0007
781 MOOD ALTERED 20 0.0007
782 PULMONARY FIBROSIS 14 0.0007
783 PERIPHERAL COLDNESS 10 0.0007
784 THIRST 13 0.0007
785 ABDOMINAL DISCOMFORT 122 0.0007
786 GLAUCOMA 14 0.0007
787 PAIN IN EXTREMITY 213 0.0007
788 CYSTITIS 23 0.0007
789 DIVERTICULITIS 20 0.0007
790 VISION BLURRED 99 0.0007
791 SKIN DISORDER 24 0.0007
792 OEDEMA 39 0.0007
793 PANCREATITIS 38 0.0007
794 ARRHYTHMIA 34 0.0007
795 RASH 312 0.0007
796 VAGINAL HAEMORRHAGE 31 0.0007
797 RASH PAPULAR 16 0.0007
798 KIDNEY INFECTION 14 0.0007
799 BONE DISORDER 13 0.0007
800 THROAT IRRITATION 32 0.0007
801 THROAT TIGHTNESS 19 0.0007
802 HAEMATURIA 24 0.0007
803 LIMB INJURY 19 0.0007
804 INCORRECT ROUTE OF DRUG ADMINISTRATION 25 0.0007
805 SPINAL FRACTURE 14 0.0007
806 HEPATIC FAILURE 21 0.0007
807 MULTI-ORGAN FAILURE 12 0.0007
808 HEPATIC CIRRHOSIS 13 0.0007
809 EXTRA DOSE ADMINISTERED 28 0.0007
810 MYALGIA 117 0.0007
811 HYPOCALCAEMIA 13 0.0007
812 SENSORY DISTURBANCE 11 0.0007
813 EPISTAXIS 51 0.0007
814 HEAD DISCOMFORT 12 0.0007
815 HOT FLUSH 51 0.0007
816 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
817 DYSPHAGIA 64 0.0007
818 CARDIAC FAILURE 54 0.0007
819 EAR PAIN 13 0.0007
820 BLOOD PRESSURE FLUCTUATION 16 0.0007
821 MOUTH ULCERATION 14 0.0007
822 GAIT DISTURBANCE 127 0.0007
823 URTICARIA 111 0.0007
824 DRUG INTOLERANCE 64 0.0007
825 LOCALISED INFECTION 16 0.0007
826 CARDIAC FAILURE CONGESTIVE 53 0.0007
827 STOMATITIS 40 0.0007
828 ATRIAL FIBRILLATION 64 0.0007
829 HAEMATOMA 17 0.0007
830 ABDOMINAL PAIN UPPER 135 0.0007
831 JOINT INJURY 14 0.0007
832 DEAFNESS 17 0.0006
833 THERAPY CESSATION 33 0.0006
834 OFF LABEL USE 561 0.0006
835 VERTIGO 39 0.0006
836 CONDITION AGGRAVATED 193 0.0006
837 PROTEINURIA 12 0.0006
838 PRURITUS 242 0.0006
839 INFLUENZA 70 0.0006
840 RASH ERYTHEMATOUS 30 0.0006
841 ABSCESS 10 0.0006
842 POST PROCEDURAL COMPLICATION 12 0.0006
843 POLLAKIURIA 26 0.0006
844 ANOSMIA 9 0.0006
845 LYMPHADENOPATHY 22 0.0006
846 NIGHT SWEATS 20 0.0006
847 SURGERY 36 0.0006
848 TINNITUS 28 0.0006
849 METASTASES TO BONE 10 0.0006
850 ACTIVITIES OF DAILY LIVING IMPAIRED 12 0.0006
851 LIVER FUNCTION TEST INCREASED 13 0.0006
852 GENERAL PHYSICAL HEALTH DETERIORATION 70 0.0006
853 FATIGUE 470 0.0006
854 CONTUSION 58 0.0006
855 MEMORY IMPAIRMENT 82 0.0006
856 ABDOMINAL PAIN LOWER 15 0.0006
857 MOVEMENT DISORDER 19 0.0006
858 MUSCULOSKELETAL PAIN 31 0.0006
859 BACTERIAL INFECTION 11 0.0006
860 THROMBOSIS 47 0.0006
861 GASTRIC DISORDER 20 0.0006
862 DYSSTASIA 17 0.0006
863 LIMB DISCOMFORT 18 0.0006
864 URINARY TRACT INFECTION 99 0.0006
865 MUSCLE SPASMS 106 0.0006
866 LABORATORY TEST ABNORMAL 17 0.0006
867 LOCAL SWELLING 10 0.0006
868 ALANINE AMINOTRANSFERASE INCREASED 35 0.0006
869 DRUG ERUPTION 10 0.0006
870 APHASIA 17 0.0006
871 INTENTIONAL DOSE OMISSION 16 0.0006
872 RED BLOOD CELL COUNT DECREASED 16 0.0006
873 MUSCULOSKELETAL STIFFNESS 49 0.0006
874 SINUSITIS 57 0.0006
875 CLOSTRIDIUM DIFFICILE INFECTION 12 0.0005
876 RENAL IMPAIRMENT 46 0.0005
877 INFLUENZA LIKE ILLNESS 45 0.0005
878 CHILLS 64 0.0005
879 PRODUCT ADMINISTRATION ERROR 11 0.0005
880 LIP SWELLING 18 0.0005
881 NEUROPATHY PERIPHERAL 51 0.0005
882 PHOTOPHOBIA 10 0.0005
883 DIARRHOEA 343 0.0005
884 BONE PAIN 31 0.0005
885 ASPARTATE AMINOTRANSFERASE INCREASED 28 0.0005
886 OSTEONECROSIS OF JAW 13 0.0005
887 PRODUCT USE IN UNAPPROVED INDICATION 130 0.0005
888 PERIPHERAL SWELLING 80 0.0005
889 MUSCULAR WEAKNESS 59 0.0005
890 EYE DISORDER 17 0.0005
891 ILLNESS 53 0.0005
892 COGNITIVE DISORDER 24 0.0005
893 PRODUCT DOSE OMISSION ISSUE 151 0.0005
894 IRRITABLE BOWEL SYNDROME 11 0.0005
895 THERAPEUTIC RESPONSE DECREASED 31 0.0005
896 HYPOACUSIS 22 0.0005
897 ILL-DEFINED DISORDER 31 0.0005
898 FUNGAL INFECTION 17 0.0005
899 HYPOPHAGIA 13 0.0005
900 BLOOD PRESSURE ABNORMAL 10 0.0005
901 NEPHROLITHIASIS 23 0.0005
902 PRESCRIBED UNDERDOSE 10 0.0005
903 ADVERSE DRUG REACTION 45 0.0005
904 MELAENA 11 0.0005
905 BLOOD GLUCOSE DECREASED 24 0.0005
906 STEVENS-JOHNSON SYNDROME 11 0.0005
907 FEEDING DISORDER 10 0.0005
908 UNEVALUABLE EVENT 37 0.0005
909 EAR INFECTION 13 0.0005
910 PRODUCT SUBSTITUTION ISSUE 28 0.0005
911 EXTRAPYRAMIDAL DISORDER 12 0.0005
912 JAUNDICE 13 0.0005
913 NERVOUS SYSTEM DISORDER 15 0.0005
914 ARTHRALGIA 199 0.0005
915 OCULAR HYPERAEMIA 22 0.0005
916 TARDIVE DYSKINESIA 13 0.0005
917 CARDIAC DISORDER 43 0.0005
918 HAEMORRHAGE 48 0.0005
919 JOINT STIFFNESS 12 0.0005
920 NEURALGIA 11 0.0005
921 BLOOD GLUCOSE INCREASED 85 0.0005
922 ADVERSE EVENT 41 0.0004
923 CHROMATURIA 10 0.0004
924 NEUTROPHIL COUNT DECREASED 18 0.0004
925 DRY EYE 22 0.0004
926 RHINORRHOEA 28 0.0004
927 SKIN BURNING SENSATION 31 0.0004
928 ARTHRITIS 34 0.0004
929 LACRIMATION INCREASED 13 0.0004
930 SKIN EXFOLIATION 36 0.0004
931 ANAPHYLACTIC SHOCK 11 0.0004
932 MULTIPLE SCLEROSIS RELAPSE 29 0.0004
933 FLUSHING 43 0.0004
934 INFECTION 61 0.0004
935 VISUAL IMPAIRMENT 52 0.0004
936 FLUID RETENTION 21 0.0004
937 RENAL DISORDER 19 0.0004
938 ECZEMA 21 0.0004
939 THERAPY NON-RESPONDER 18 0.0004
940 ARTHROPATHY 22 0.0004
941 OSTEONECROSIS 13 0.0004
942 PLATELET COUNT DECREASED 42 0.0004
943 MOBILITY DECREASED 28 0.0004
944 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
945 FEMUR FRACTURE 12 0.0004
946 RESPIRATORY TRACT INFECTION 10 0.0004
947 LIVER DISORDER 17 0.0004
948 DISCOMFORT 23 0.0004
949 PANCYTOPENIA 21 0.0004
950 NASOPHARYNGITIS 69 0.0004
951 ASCITES 11 0.0004
952 HEPATIC ENZYME INCREASED 25 0.0004
953 IMPAIRED HEALING 12 0.0004
954 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
955 VIRAL INFECTION 12 0.0004
956 DRUG EFFECT DECREASED 19 0.0004
957 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
958 JOINT SWELLING 42 0.0003
959 MULTIPLE SCLEROSIS 16 0.0003
960 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
961 PSORIATIC ARTHROPATHY 13 0.0003
962 GASTROINTESTINAL DISORDER 28 0.0003
963 DEATH 269 0.0003
964 DYSPHONIA 18 0.0003
965 DRY SKIN 41 0.0003
966 ACCIDENTAL EXPOSURE TO PRODUCT 31 0.0003
967 NEOPLASM MALIGNANT 20 0.0003
968 INJECTION SITE MASS 11 0.0003
969 THERAPY INTERRUPTED 21 0.0003
970 MALIGNANT NEOPLASM PROGRESSION 30 0.0003
971 PLASMA CELL MYELOMA 11 0.0003
972 DISEASE PROGRESSION 33 0.0003
973 INFLAMMATION 14 0.0003
974 HERPES ZOSTER 15 0.0003
975 NO ADVERSE EVENT 47 0.0003
976 PSORIASIS 33 0.0003
977 COVID-19 44 0.0003
978 EYE PAIN 14 0.0002
979 BLINDNESS 10 0.0002
980 INJECTION SITE PRURITUS 16 0.0002
981 CATARACT 14 0.0002
982 DISEASE RECURRENCE 11 0.0002
983 ALOPECIA 45 0.0002
984 DERMATITIS ATOPIC 12 0.0002
985 RHEUMATOID ARTHRITIS 25 0.0002
986 INJECTION SITE REACTION 13 0.0002
987 TREATMENT FAILURE 15 0.0002
988 EYE IRRITATION 10 0.0002
989 INJECTION SITE PAIN 47 0.0002
990 INJECTION SITE SWELLING 10 0.0001
991 DEVICE ISSUE 11 0.0001
992 ACNE 9 0.0001
993 INJECTION SITE ERYTHEMA 14 0.0001